BUZIO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 4.473
EU - Europa 3.611
AS - Asia 2.082
SA - Sud America 167
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 10.411
Nazione #
US - Stati Uniti d'America 4.360
CN - Cina 1.070
SG - Singapore 792
IE - Irlanda 689
UA - Ucraina 575
SE - Svezia 573
FI - Finlandia 549
IT - Italia 480
DE - Germania 313
NL - Olanda 171
TR - Turchia 171
BR - Brasile 150
GB - Regno Unito 121
CA - Canada 105
RU - Federazione Russa 52
CI - Costa d'Avorio 48
BE - Belgio 23
AT - Austria 17
FR - Francia 12
IN - India 11
EU - Europa 8
AR - Argentina 7
UZ - Uzbekistan 7
BD - Bangladesh 5
IL - Israele 5
JP - Giappone 5
AU - Australia 4
MA - Marocco 4
MX - Messico 4
PT - Portogallo 4
RO - Romania 4
ZA - Sudafrica 4
CH - Svizzera 3
EC - Ecuador 3
ES - Italia 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
HK - Hong Kong 2
HR - Croazia 2
IR - Iran 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
GE - Georgia 1
GL - Groenlandia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 10.411
Città #
Dublin 688
Chandler 656
Jacksonville 641
Singapore 456
Santa Clara 411
Dearborn 336
Beijing 277
Ashburn 266
Boardman 214
Nanjing 202
Ann Arbor 176
Izmir 154
Princeton 149
San Mateo 129
Wilmington 112
Toronto 93
Parma 78
Shanghai 59
Woodbridge 56
Shenyang 51
Kunming 50
Nanchang 50
Abidjan 48
New York 48
Helsinki 45
Hebei 44
Hefei 44
Moscow 44
Jinan 40
Tianjin 36
Los Angeles 32
Bremen 30
Des Moines 26
Milan 25
Rome 25
Brussels 23
Changsha 22
Guangzhou 22
Jiaxing 22
Houston 21
Auburn Hills 17
Norwalk 15
Fremont 14
Vienna 14
Kocaeli 12
Seattle 12
Zhengzhou 10
Council Bluffs 8
Haikou 8
Ningbo 8
São Paulo 8
Falls Church 7
London 7
Wuhan 7
Ansbach 6
Fuzhou 6
Lanzhou 6
Leiden 6
Pisa 6
Rio de Janeiro 6
Rockville 6
Tashkent 6
Wenzhou 6
Curitiba 5
Dallas 5
Hangzhou 5
Napoli 5
Ottawa 5
Rapolla 5
Taizhou 5
Torino 5
Ardea 4
Atlanta 4
Augusta 4
Belo Horizonte 4
Bologna 4
Brescia 4
Catania 4
Nuremberg 4
Pescara 4
Porto Alegre 4
Pune 4
Rio Saliceto 4
Tel Aviv 4
Verona 4
Baotou 3
Bari 3
Cutrofiano 3
Fairfield 3
Frankfurt am Main 3
Istanbul 3
Jesi 3
Madrid 3
Montréal 3
Mumbai 3
Nocera Inferiore 3
Qingdao 3
Redmond 3
Redwood City 3
Taiyuan 3
Totale 6.243
Nome #
Periaortite cronica e vasculite dei piccoli vasi 212
Miocardite eosinofila in corso di sindrome ipereosinofila idiopatica: descrizione di un caso 212
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 128
The kidney donor profile index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: Distribution and association with graft outcomes 124
Anti-fibroblast antibodies in patients with idiopathic retroperitoneal fibrosis 121
Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. 121
Periaortite cronica e vasculite dei piccoli vasi: studio morfologico-clinico 113
PROTEIN-INDUCED CHANGES IN KIDNEY-FUNCTION DEPEND ON THE TIME OF ADMINISTRATION BUT NOT ON THE DIETARY SOURCE 112
ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis? 111
Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient. 105
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 105
Churg-Strauss syndrome. 99
Autoantibodies to fibroblasts in systemic sclerosis 96
CC chemokine receptor 5 polymorphism in chronic periaortitis. 95
Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies 94
Asbestos and Smoking as Risk Factors for Idiopathic Retroperitoneal Fibrosis 92
Chronic periaortitis: a spectrum of diseases 89
Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms. 89
PTPN22 R620W polymorphism in the ANCA-associated vasculitides. 89
EBV-associated leukoencephalopathy with late onset of central nervous system lymphoma in a kidney transplant recipient. 89
Chronic periaortitis and HLA–DRB1*03: Another clue to an autoimmune origin 89
Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature 89
Granulomatosi di Wegener 88
La poliangite microscopica 86
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 86
Immunoglobulin G inhibit endothelial activation induced by atherogenic stimuli 86
IL TRATTAMENTO DEL LAPAROCELE NEL PAZIENTE TRAPIANTATO DI RENE 86
Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis 86
Sullo spostamento del rapporto pressione arteriosa/natriuresi valutato nella fase pre-ipertensiva del modello sperimentale dei ratti spontaneamente ipertesi (SHR) 85
Il tubulo-interstizio e il riassorbimento delle proteine filtrate 85
Trends in Immune Cell Function Assay and Donor-Specific HLA Antibodies in Kidney Transplantation: A 3-Year Prospective Study 85
Chronically administered immunotherapy with low-dose IL-2 and IFN-α in metastatic renal cell carcinoma: A feasible option for patients with a good prognostic profile 85
L’interessamento del sistema nervoso periferico nelle vasculiti ANCA associate 84
Immunoterapia con basse dosi di rIL-2 e rIFN alfa nel carcinoma a cellule renali metastatico: effetti immunologici 82
Prognostic significance of albuminuria in patients with renal cell cancer 80
Interferon-alfa in combination with ribavirin as initial treatment for HCV-associated membranoproliferative glomerulonephritis 80
Treatment of Erdheim-Chester disease with sirolimus. Report of a case” (Poster) 80
Anti-fibroblast antibodies in retroperitoneal fibrosis 80
Screening of helicobacter pylori infection in acquired glomerular nephropathies: preliminary results 79
Immunoglobulins G inhibit endothelial activation induced by atherogenic stimuli 79
Ear, nose and throat manifestations of Churg-Strauss syndrome. 79
Tamoxifene e fibrosi retroperitoneale 78
Respiratory system involvement in ANCA-associated systemic vasculitides 78
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin 78
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome 77
OCTREOTIDE IN THE TREATMENT OF LYMPHORREA AFTER RENAL TRANSPLANTATION: A PRELIMINARY EXPERIENCE 77
Efficacy of a Regimen of Chronic Low Dose of Interleukin-2 (IL-2) and a-Interferon (INF-a) in Metastatic Renal Cell Cancer (MRCC) 77
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 76
Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway 76
Large bowel obstruction heralding Churg-Strauss syndrome 75
Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals 75
Normal human IgG prevents endothelial cell activation induced by TNFalpha and oxidized low-density lipoprotein atherogenic stimuli 74
Long-term treatment with low doses of interleukin-2 and interferon-alpha: immunological effects in advanced renal cell cancer 74
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. 74
Idiopathic and secondary forms of retroperitoneal fibrosis: A diagnostic approach 74
A randomised trial of tamoxifen and prednisone in idiopathic retroperitoneal fibrosis 74
IL TRAPIANTO DI RENE-PANCREAS COMBINATO. RISULTATI DEL CENTRO DI PARMA. 74
Orofacial granulomatosis treated with low-level laser therapy: a case report 73
Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? 73
Evidence of autoimmunity in chronic periaortitis: a prospective study 72
Chronic periaortitis and autoimmune thyroiditis: A novel association 72
Increased viral load after intravenous immunoglobulin therapy for BK virus-associated nephropathy 71
Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: Insights into mechanisms of myocardial cell death 70
Retroperitoneal fibrosis 69
Changes in lymphocyte count induced by repeated cycles with low-dose interleukin-2 and interferon-α in 146 patients with renal cell carcinoma. 69
Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: A case–control study 69
(18)F-flurodeoxyglucose positron emission tomography in the diagnosis and follow-up of idiopathic retroperitoneal fibrosis 68
Albuminuria as prognostic factor in renal cell cancer 68
Low doses of subcutaneous interleukin-2 plus interferon-alfa do not induce thyroid function alterations in advance renal cell carcinoma 67
Neuropatie vasculitiche: uno studio prospettico clinico ed elettrofisiologico 67
Inquadramento clinico delle vasculiti sistemiche 67
Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients 67
Calciphylaxis: evolving concepts. 66
Outcome and prognostic factors during the course of primary small-vessel vasculitides. 66
Alterazioni renali correlate con l’artrite reumatoide 66
Subclinical interstitial lung abnormalities in stable renal allograft recipients in the era of modern immunosuppression. 66
Tuberculosis as a trigger of retroperitoneal fibrosis 65
Role of Chemotherapy With Gemcitabine Plus 5-fluorouracil and Chemoimmunotherapy in Metastatic Renal Cell Cancer (mRCC) 65
Tamoxifen vs prednisone in patients with retroperitoneal fibrosis:preliminary results of a randomised clinical trial 64
Effect of conjugated estrogens on free IGF-I? 64
Ipertrofia ventricolare sinistra e sistema nitrossidergico miocardio nella fase pre-ipertensiva del modello sperimentale SHR 64
Renal involvement in Churg-Strauss syndrome. 64
Prevalence of autoantibodies against structure specific recognition protein 1 in systemic lupus erythematosus 64
Significato prognostico di alcuni parametri immunologici in pazienti con carcinoma a cellule renali metastatico trattati con dosaggi molto bassi di rIL-2 e rIFNa 64
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer 64
L’interessamento renale nelle vasculiti sistemiche. La granulomatosi di Wegener 63
Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma 63
Rhinologic manifestations of small-vessel systemic vasculitides. 63
Diagnosis of Churg-Strauss syndrome: eotaxin-3 makes it easier. 63
Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma 62
Immunoterapia (IT) combinata a basse dosi nel carcinoma renale a cellule chiare (RCC) metastatico 62
L’interessamento renale nelle vasculiti sistemiche. La granulomatosi di Wegener 61
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-alpha for metastatic renal cell cancer 61
“Late” regression of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen 61
Inquadramento diagnostico e classificazione delle vasculite sistemiche 60
HCV-RELATED CRYOGLOBULINEMIC GLOMERULONEPHRITIS: IMPLICATIONS OF ANTIVIRAL AND IMMUNOSUPPRESSIVE THERAPIES 60
Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome 60
Rituximab therapy for chronic periaortitis. 60
Tamoxifene versus prednisone nella terapia medica della fibrosi retroperitoneale idiomatica 60
Crioglobulinemia mista e glomerulonefrite associate ad infezione cronica da virus dell’epatite C (HCV) 59
Totale 8.068
Categoria #
all - tutte 38.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020316 0 0 0 0 0 0 0 0 0 132 42 142
2020/2021963 12 143 115 7 133 18 125 11 197 34 159 9
2021/2022691 8 14 3 40 16 12 106 131 36 55 73 197
2022/20232.453 302 227 132 189 254 268 25 132 829 7 66 22
2023/2024673 42 79 20 20 67 187 21 67 14 41 39 76
2024/20251.972 75 168 183 106 352 339 82 135 321 211 0 0
Totale 10.438